Despite currently being produced for under $five per month, copyright carries a retail price tag which is tough to justify. The significant gap in between output expenditures and pricing raises important questions about the pharmaceutical business's pricing tactics.California biotech behemoth Amgen ditched ideas for an experimental weight loss pill